Infinx Acquires MedReceivables to Boost Pathology Revenue Solutions

Infinx, a provider of AI-powered solutions for patient access and revenue cycle management, has acquired MedReceivables Advisor (MRA), a leader in pathology billing and revenue cycle management for hospital based-practices. The partnership brings a host of new services and strengthens Infinx’s support for healthcare providers and reducing their administrative burdens.
 
By bringing MRA’s pathology expertise into its portfolio, Infinx offers advanced solutions in pathology coding and billing, litigation support and managed care contracting, credentialing support, payer contract reviews, and fee schedule monitoring. It also brings key strengths in eligibility verification, A/R and denials management, and even litigation support, providing a set of solutions that aligns with Infinx’s mission to capture more revenue for healthcare organizations.
 
Jaideep Tandon, CEO, Infinx, stated, “We are happy to welcome MRA to the Infinx family. Their experience in pathology billing and revenue cycle services is a natural fit with our vision to bridge providers, patients, and payers with technology. Together, we’re positioned to help our clients thrive with more powerful, connected solutions.”
 
David Smith, CEO, MRA, highlighted the advantages for MRA clients stating, “Joining Infinx allows us to offer a broader range of solutions that our clients have been looking for. With Infinx’s increased focus on security, including HITRUST certification, and their expertise in AI, this partnership opens exciting new doors for both our clients and our team.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!